Cross-sectional study highlights barriers limiting biologic use in psoriasis, suggesting targeted solutions.
Persistent educational and structural barriers continue to limit optimal biologic use despite formal availability, highlighting the need for targeted education, streamlined care pathways, and improved physician-patient communication to achieve equitable outcomes.
No takes yet. Share an insight, caveat, or question.
Leite et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: